acitretin has been researched along with 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drainas, D; Magoulas, G; Papadimou, E; Papaioannou, D | 1 |
| elAttar, TM; Lin, HS | 1 |
| Hirschel-Scholz, S; Saurat, JH; Siegenthaler, G | 1 |
| Gollnick, H; Orfanos, CE | 1 |
| Corbeil, J; Looney, DJ; Rapaport, E; Richman, DD | 1 |
| Chen, X; Deng, P; Tang, Y; Wang, Y; Zhang, H; Zhong, D | 1 |
1 trial(s) available for acitretin and 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid
| Article | Year |
|---|---|
[Etretinate: pro and con. Risk-benefit analysis of systemic retinoid therapy in psoriasis and recent developments: free aromatic acid, arotinoids].
Topics: Abnormalities, Drug-Induced; Acitretin; Benzoates; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Etretinate; Humans; Lipids; Long-Term Care; Prognosis; Psoriasis; Retinoids; Risk; Skin; Tretinoin | 1985 |
5 other study(ies) available for acitretin and 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid
| Article | Year |
|---|---|
Preparation of spermine conjugates with acidic retinoids with potent ribonuclease P inhibitory activity.
Topics: Animals; Dictyostelium; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Molecular Structure; Ribonuclease P; Spermine; Stereoisomerism; Tretinoin | 2009 |
In vitro inhibition of prostaglandin biosynthesis in squamous cell carcinoma by retinoids.
Topics: Acitretin; Arachidonic Acid; Arachidonic Acids; Benzoates; Carcinoma, Squamous Cell; Dinoprostone; Dose-Response Relationship, Drug; Etretinate; Humans; Prostaglandin-Endoperoxide Synthases; Retinoids; Tongue Neoplasms; Tretinoin; Tumor Cells, Cultured | 1990 |
Isotretinoin differs from other synthetic retinoids in its modulation of human cellular retinoic acid binding protein (CRABP).
Topics: Acitretin; Acne Vulgaris; Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Benzoates; Carrier Proteins; Female; Humans; Isotretinoin; Male; Middle Aged; Receptors, Retinoic Acid; Retinoids; Skin; Time Factors; Tretinoin | 1989 |
Antiproliferative effect of retinoid compounds on Kaposi's sarcoma cells.
Topics: Acitretin; Benzoates; Cell Division; Fibroblast Growth Factor 2; Humans; Interleukin-6; Isotretinoin; Male; Receptors, Fibroblast Growth Factor; Receptors, Interleukin; Receptors, Interleukin-6; Retinoids; RNA, Messenger; Sarcoma, Kaposi; Tretinoin; Tumor Cells, Cultured | 1994 |
Determination of arotinoid acid in human plasma by liquid chromatography-tandem mass spectrometry.
Topics: Acitretin; Benzoates; Chromatography, Liquid; Drug Stability; Humans; Least-Squares Analysis; Male; Reproducibility of Results; Retinoids; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry | 2009 |